Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
Clinical trial NCT07033689 · RECRUITING
Trial details
- NCT number
- NCT07033689
- Sponsor
- SONIRE Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2026-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.